Vaxxinity
Blood & Organ Banks · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
505 Odyssey Way, Merritt Island, Florida...Phone Number
(254) 244-5739Website
www.vaxxinity.comRevenue
<$5 MillionStock Symbol
VAXXIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
3
2
About Vaxxinity
Vaxxinity is a biotechnology company developing a new class of immunotherapeutic vaccines to combat chronic disorders and infectious diseases. The company is headquartered in Dallas, Texas.Explore more
Vaxxinity Org Chart
JS
President of Sequoia Brain and Spine, Inc.
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vaxxinity your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Vaxxinity launches new products
Check if Vaxxinity has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Vaxxinity
Website visits: Recent activity has been detected on your website
Click to see if Vaxxinity had a recent Job posting/layoffs
Vaxxinity, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Vaxxinity recently announced quarterly report
Funding: Get notified immidiatlly once Vaxxinity has new funding data
Check out if Vaxxinity is spiking on competitors!
Recommended Actions
Find VP level buyers at Vaxxinity
Find 2 more new buyers
Compare Similar Companies to Vaxxinity
Compare insights from companies similar to Vaxxinity, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vaxxinity is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Vaxxinity is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Vaxxinity.
Vaxxinity Tech Stack
A closer look at the technologies used by Vaxxinity
Most Recent Scoops
Event
Person-Based
Events, Artificial Intelligence, Robotics, Podcast
Event
Person-Based
Peter Diamandis appeared on a podcast called "Raoul Pal: The Journey Man" on 04/23/2026. Topics discussed include AI, Exponential Technologies, Disruption.
Events, Artificial Intelligence, Corporate Strategy, Podcast
Lateral Move
Executive Move
New Hire
Executive Move
Board of Directors
New Hire
Executive Move
Board of Directors
Vaxxinity News & Media
Vaxxinity Issues Shareholder Letter
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced issued a letter to shareholders from its Co-founder and Executive Chairman, Lou Reese and Chief Executive Officer, Mei Mei Hu.Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced its intention to voluntarily delist from the Nasdaq Global Market (“Nasdaq”) and to deregister its Class A common stock under Section 12(b) and Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and suspend its reporting obligations underVaxxinity Appoints Dr. Peter Powchik as Global Scientific Director
By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it appointed Peter Powchik, M.D. as Executive Vice President, Global Scientific Director overseeing its scientific direction and lead development efforts. Powchik was previously Senior Vice President at Regeneron Pharmaceuticals, the company said. Additionally, Ulo Palm, M.D., will transition from Chief Medical Officer to senior advisor, it said. […]Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Phase 1 Clinical Trial in Parkinson’s Disease
UB-312 was immunogenic in patients with early Parkinson’s disease.
Read more news
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Vaxxinity
Sign Up For FreeTo access detailed company insights
Vaxxinity is a biotechnology company developing a new class of immunotherapeutic vaccines to combat chronic disorders and infectious diseases. The company is headquartered in Dallas, Texas.... Read More
